Figure S1-9; Supplementary Methods from VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
Xiaosai Yao,Jing Tan,Kevin Junliang Lim,Joanna Koh,Wen Fong Ooi,Zhimei Li,Dachuan Huang,Manjie Xing,Yang Sun Chan, James Zhengzhong Qu,Su Ting Tay, Giovani Wijaya,Yue Ning Lam,Jing Han Hong,Ai Ping Lee-Lim,Peiyong Guan,Michelle Shu Wen Ng, Cassandra Zhengxuan He,Joyce Suling Lin,Tannistha Nandi,Aditi Qamra,Chang Xu, Swe,James O. J. Davies,Jian Yuan Goh,Gary Loh,Bryan C. Tan,Steven G. Rozen,Qiang Yu,Iain Bee Huat Tan,Christopher Wai Sam Cheng,Shang Li,Kenneth Tou En Chang,Puay Hoon Tan,David Lawrence Silver,Alexander Lezhava,Gertrud Steger,Jim R. Hughes,Bin Tean Teh,Patrick Tan openalex（2023）
关键词
Renal Cell Carcinoma,Clinical Guidelines
AI 理解论文
溯源树
样例
